390401-24-8 Usage
Uses
Used in Pharmaceutical Industry:
2-(Benzylaminoethoxy)tetrahydropyran is used as a key intermediate in the synthesis of potential CB1 antagonists for the treatment of various conditions, such as obesity, metabolic disorders, and pain management. Its unique chemical structure allows for the development of novel compounds with improved pharmacological properties and selectivity.
Used in Research and Development:
In addition to its pharmaceutical applications, 2-(benzylaminoethoxy)tetrahydropyran is also utilized in research and development for the exploration of new chemical entities and their potential therapeutic applications. Its versatile structure makes it a valuable tool for medicinal chemists in the design and optimization of novel drug candidates.
Check Digit Verification of cas no
The CAS Registry Mumber 390401-24-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,0,4,0 and 1 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 390401-24:
(8*3)+(7*9)+(6*0)+(5*4)+(4*0)+(3*1)+(2*2)+(1*4)=118
118 % 10 = 8
So 390401-24-8 is a valid CAS Registry Number.
390401-24-8Relevant academic research and scientific papers
POLYMORPHS OF 3-CHLORO-4[(2R)-2
-
Page/Page column 36, (2012/07/13)
Polymorphs of 3-chloro-4[(2R)-2-(4-chlorophenyl)-4-[(1R)-1-(4-cyanophenyl)ethyl]-1- piperazinyl]-benzonitrile are disclosed, as well as pharmaceutical compositions comprising said polymorphs, methods of using the polymorphs, and a process for preparing them.
SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS
-
Page/Page column 168, (2009/03/07)
Compounds of Formula (I) or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
